200 Participants Needed

Biospecimen Collection for HIV/AIDS-Related Cancer

Recruiting at 9 trial locations
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: AIDS Malignancy Consortium
Must be taking: Antiretrovirals
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on collecting blood and tissue samples to study HIV-related cancers. Researchers aim to understand how biological or genetic factors contribute to these cancers in people living with HIV. Individuals who are HIV-positive and have been diagnosed with an HIV-linked cancer, such as Kaposi sarcoma or Hodgkin's lymphoma, might be suitable candidates. The goal is to gather insights that could lead to better treatments in the future. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future cancer treatments for people living with HIV.

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants must have documentation of receiving antiretroviral therapy (ART) for HIV, so you may need to continue those medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on collecting blood and tissue samples from patients with HIV/AIDS-related cancers, which is crucial for understanding these complex conditions. Unlike standard treatments that target the cancer directly, this biospecimen collection aims to provide researchers with valuable biological material to study the unique interactions between HIV and cancer. By examining fresh blood and tumor samples, scientists hope to uncover new insights and potentially develop more effective, targeted therapies in the future.

Who Is on the Research Team?

JB

Jeff Bethony

Principal Investigator

AIDS Malignancy Consortium

Are You a Good Fit for This Trial?

Inclusion Criteria

anal cancer
plasmablastic lymphoma
classic Kaposi sarcoma
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Biospecimen Collection

Participants donate blood and/or tissue samples for research

1 visit
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after biospecimen collection

4 weeks

Long-term Storage and Research

Biospecimens are stored in a biobank for future research studies

10 years

What Are the Treatments Tested in This Trial?

Interventions

  • Biospecimen Collection
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Observational (biospecimen collection)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

AIDS Malignancy Consortium

Lead Sponsor

Trials
64
Recruited
9,600+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security